15
9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T72058L | CDD-1102 HCl | CDD-1102 HCl(2757619-84-2 Free base) | Epigenetic Reader Domain |
CDD-1102 HCl is a novel BRDT-BD4 / BRD2-BD1302 selective inhibitor that shows non-hormonal contraceptive potential in ex vivo experiments. | |||
T79344 | CDD-1819 | SARS-CoV | |
CDD-1819, a non-covalent and non-peptide compound, serves as a potent SARS-CoV-2 Mpro inhibitor, exhibiting a K i value of 5 nM. It also effectively inhibits the Mpro variants ΔP168, A173V, and ΔP168/A173V [1]. | |||
T79345 | CDD-1733 | SARS-CoV | |
CDD-1733 is a potent, non-covalent, and non-peptide inhibitor of the SARS-CoV-2 main protease (Mpro) with an inhibition constant (K i) of 12 nM. It effectively inhibits Mpro variants including ΔP168, A173V, and the combi... | |||
T79346 | CDD-1845 | SARS-CoV | |
CDD-1845, a non-covalent, non-peptide inhibitor, exhibits potent inhibition of SARS-CoV-2 M^pro with a K_i value of 3 nM. Additionally, CDD-1845 is effective against M^pro variants ΔP168, A173V, and the combined ΔP168/A1... | |||
T13600 | CDD3505 | 4-nitro-1-trityl-1H-imidazole | P450 |
CDD3505 (4-nitro-1-trityl-1H-imidazole) increases high-density lipoprotein cholesterol by targeting hepatic CYP3A. | |||
T13601 | CDD3506 | 1-TRITYL-1H-IMIDAZOL-4-AMINE | P450 |
CDD3506 (1-TRITYL-1H-IMIDAZOL-4-AMINE) increases high-density lipoprotein cholesterol by targeting hepatic CYP3A. | |||
T39126 | Zunsemetinib | CDD-450,ATI-450 | |
Zunsemetinib (CDD-450) is a potent and specific inhibitor of the p38α-MK2 pathway, exerting its effects through oral administration. It has proven activity against immuno-inflammatory diseases, making it a valuable tool ... | |||
TP2357 | Ularitide | CDD 95-126,ANP 95-126,Human urodilatin | |
Ularitide is a 32-amino acid peptide derived from (95-126 residues) of ANP PROHORMONE (1-126 residues). It isn't biologically inactivated by a peptidase from dog kidney cortex membranes. | |||
T10731 | CDD0102 | CDD0102A | AChR |
CDD0102 is a potent agonist of M1 Muscarinic receptor. | |||
T10733 | CDDO-EA | TP319,CDDO ethyl amide,RTA 405 | Nrf2 |
CDDO-EA (CDDO ethyl amide) is an activator of the Nrf2/antioxidant response element. | |||
TQ0120 | CDDO-Im | RTA-403,CDDO-Imidazolide,TP-235 | Others , Ferroptosis , Nrf2 , PPAR |
CDDO-Im (TP-235) is an activator of Nrf2 and PPAR (Kis: 232/344 nM for PPARα/PPARγ). | |||
T13604 | CDDO-dhTFEA | Others , NF-κB , Nrf2 | |
CDDO-dhTFEA, a synthetic oleanane triterpenoid, effectively activates Nrf2 while inhibiting the NF-κB pro-inflammatory transcription factor. It restores mean arterial pressure (MAP), elevates Nrf2 levels and the expressi... | |||
T80662 | CDD0102 HCl | CDD0102A HCl | AChR |
CDD0102 HCl is a selective and potent M1 muscarinic receptor agonist for the treatment of Alzheimer's disease. | |||
T13603 | CDDO-3P-Im | Necroptosis | |
CDDO-3P-Im is an orally active inhibitor of necroptosis with chemopreventive effects. CDDO-3P-Im can be used in studies about ischemia/reperfusion. | |||
T13602 | CDDO-2P-Im | CDDO-2-P-Im | Others |
CDDO-2P-Im shows chemopreventive effect and reduces the size and severity of the lung tumors in the mouse lung cancer model. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00925 | SOST Protein, Human, Recombinant (His) | Human | HEK293 Cells |
SOST Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 22.5 kDa and the accession number is Q9BQB4-1. | |||
TMPY-05113 | SOST Protein, Human, Recombinant (His), Biotinylated | Human | HEK293 Cells |
SOST Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 22.5 kDa and the accession number is Q9BQB4-1. | |||
TMPK-01293 | SOST Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells |
SOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. SOST is negative regulator of bone growth that acts through inhibition of ... | |||
TMPH-01178 | CDA Protein, Human, Recombinant (His & Myc) | Human | E. coli |
CDA Protein, Human, Recombinant (His & Myc) is expressed in E. coli. | |||
TMPK-00102 | SOST Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
SOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. SOST is negative regulator of bone growth that acts through inhibition of ... | |||
TMPK-00103 | SOST Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
SOST, also known as sclerostin, is a member of the cerberus/DAN family, a group of secreted glycoproteins characterized by a cysteine-knot motif. SOST is negative regulator of bone growth that acts through inhibition of ... | |||
TMPY-03046 | APCDD1 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
Osteosarcoma (OS) is the most common type of bone tumor in children and adults. The expression of APCDD1, a Wnt antagonist, was reduced in OS tissues and cells compared to adjacent normal tissue and osteoblast cells, res... | |||
TMPK-00989 | APCDD1 Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
APCDD1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 54.4 kDa and the accession number is Q3U128. | |||
TMPK-00311 | APCDD1 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
APCDD1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 54.4 kDa and the accession number is Q8J025. |